Aspire Private Capital’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Aspire Private Capital’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-98	Closed	-$14K	–	489
2019 Q2	$14K	Sell	98 -165	-63%	-$22.8K	0.01%	245
2019 Q1	$40K	Buy	263 +24	+10%	+$3.45K	0.02%	244
2018 Q4	$30K	Buy	+239	New	+$32.7K	0.02%	241

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Aspire Private Capital's FBT Position: Q3 2019 in Review

Aspire Private Capital sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2019, closing a stake of 98 shares — an estimated $14K sold.

Aspire Private Capital first reported a position in FBT in Q4 2018 and held it in 3 quarters. The position peaked at $40K in Q1 2019. 188 funds tracked by Wall St. Rank hold FBT as of Q3 2019.

Aspire Private Capital reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2019 after selling out during the quarter.
Aspire Private Capital sold 98 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2019, an estimated $14K.
Aspire Private Capital first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2018 and held it in 3 quarters.
Aspire Private Capital's First Trust NYSE Arca Biotechnology Index Fund position peaked at $40K in Q1 2019.
188 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2019.

Based on Aspire Private Capital's 13F filing for Q3 2019, filed 12 Nov 2019.